These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 15904629)
1. Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study). Vigen C; Hodis HN; Selzer RH; Mahrer PR; Mack WJ Am J Cardiol; 2005 Jun; 95(11):1277-82. PubMed ID: 15904629 [TBL] [Abstract][Full Text] [Related]
2. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review. Frisinghelli A; Mafrici A Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568 [TBL] [Abstract][Full Text] [Related]
3. Serial quantitative coronary angiography and coronary events. Mack WJ; Xiang M; Selzer RH; Hodis HN Am Heart J; 2000 Jun; 139(6):993-9. PubMed ID: 10827379 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial. Domanski M; Tian X; Fleg J; Coady S; Gosen C; Kirby R; Sachdev V; Knatterud G; Braunwald E Am J Cardiol; 2008 Oct; 102(8):1023-7. PubMed ID: 18929703 [TBL] [Abstract][Full Text] [Related]
9. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study). Patel D; Ahmad S; Silverman A; Lindsay J Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Rackley CE Clin Cardiol; 1996 Sep; 19(9):683-9. PubMed ID: 8874986 [TBL] [Abstract][Full Text] [Related]
11. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615 [TBL] [Abstract][Full Text] [Related]
12. Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM Atheroscler Suppl; 2007 Aug; 8(2):3-8. PubMed ID: 17588826 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting. Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151 [TBL] [Abstract][Full Text] [Related]
14. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial. Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095 [TBL] [Abstract][Full Text] [Related]
16. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866 [TBL] [Abstract][Full Text] [Related]
17. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet; 1994 Sep; 344(8923):633-8. PubMed ID: 7864934 [TBL] [Abstract][Full Text] [Related]
18. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). Zhao XQ; Krasuski RA; Baer J; Whitney EJ; Neradilek B; Chait A; Marcovina S; Albers JJ; Brown BG Am J Cardiol; 2009 Dec; 104(11):1457-64. PubMed ID: 19932775 [TBL] [Abstract][Full Text] [Related]
19. A prospective natural-history study of coronary atherosclerosis. Stone GW; Maehara A; Lansky AJ; de Bruyne B; Cristea E; Mintz GS; Mehran R; McPherson J; Farhat N; Marso SP; Parise H; Templin B; White R; Zhang Z; Serruys PW; N Engl J Med; 2011 Jan; 364(3):226-35. PubMed ID: 21247313 [TBL] [Abstract][Full Text] [Related]
20. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Raggi P; Callister TQ; Shaw LJ Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1272-7. PubMed ID: 15059806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]